Effectiveness of omega-3 polyunsaturated fatty acids in combination with acetylsalicylic acid in patients with COPD, complicated by cor pulmonale and the syndrome of blood hypercoagulation Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004
Omega-3 polyunsaturated fatty acids in correction of hemostasis system in patients with cor pulmonale Source: Eur Respir J 2002; 20: Suppl. 38, 100s Year: 2002
Effects of n-3 polyunsaturated fatty acids on inflammatory markers in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 39s Year: 2006
The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017
Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 1024-1029 Year: 2008
Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001
Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016 Year: 2017
Possibilities to control pulmonary hypertension in patients with COPD and pulmonary tuberculosis complicated by chronic cor pulmonale Source: Eur Respir J 2003; 22: Suppl. 45, 423s Year: 2003
Is heart type fatty acid binding protein a marker of cardiac damage in patients with acute attacks of chronic obstructive pulmonary disease? Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
Non-alcoholic fatty liver disease (NAFLD): A new mechanism for co-morbidities in chronic obstructive pulmonary disease (COPD)? Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016
The effect of folic acid supplementation on hyperhomocysteinemia and pulmonary function parameters in chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013
Effect of omega-3 and phosphoethanolamine in patients with asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Effect of nintedanib on hyaluronic acid metabolism in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Effect of simvastatin on pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 287s Year: 2007
Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012
Differential metabolism of hyaluronic acid in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007
Effects of bosentan in patients with severe pulmonary hypertension and mild-to-moderate COPD Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009
Conclusion: treatment of pulmonary hypertension in COPD patients Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange Year: 2005
Uric acid, oxidative stress and inhaled steroids in stable chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006